Literature DB >> 8503799

Coping with myasthenia gravis and implications for psychotherapy.

S Doering1, T Henze, G Schüssler.   

Abstract

The aim of this study was to investigate psychosocial influences and mechanisms of coping to establish indications for psychotherapy in patients with myasthenia gravis. We investigated clinical symptoms, personality, psychopathology, and coping in 44 patients with myasthenia gravis. The patients' personalities were not characteristically altered, and in 29.5% (13/44) of them, preexistent, long-term psychiatric disturbances (according to International Classification of Diseases criteria) were present, which corresponds to the prevalence in the average population. In general, coping was characterized by an attitude of calmness and acceptance, which is attributable to effective medical treatment and could be considered an unspecific mode of coping with chronic diseases of moderate severity. Four women had undergone psychotherapy because of neurotic symptoms that were unrelated to myasthenia gravis. At the end of psychotherapy, their myasthenic symptoms had greatly improved or disappeared. Psychotherapeutic techniques may be helpful in patients with neurotic or reactive psychiatric symptoms, but there is no general implication for psychotherapy in myasthenic patients, especially if there is adequate "somatic" therapy.

Entities:  

Mesh:

Year:  1993        PMID: 8503799     DOI: 10.1001/archneur.1993.00540060055018

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  8 in total

1.  Quality of life and life circumstances in German myasthenia gravis patients.

Authors:  Sabine Twork; Susanne Wiesmeth; Jörg Klewer; Dieter Pöhlau; Joachim Kugler
Journal:  Health Qual Life Outcomes       Date:  2010-11-11       Impact factor: 3.186

2.  Psychosocial aspects in myasthenic patients treated by plasmapheresis.

Authors:  Yu-Tai Chen; Yuanmay Chang; Hou-Chang Chiu; Jiann-Horng Yeh
Journal:  J Neurol       Date:  2011-02-02       Impact factor: 4.849

3.  The Relationship of Symptoms of Anxiety and Depression with Disease Severity and Treatment Modality in Myasthenia Gravis: A Cross-sectional Study.

Authors:  Fikret Aysal; Oğuz Karamustafalioğlu; Başak Özçelik; Meltem Yilmaz; Nesrin Karamustafalioğlu; Hüseyin Yumrukçal; Onur Tankaya
Journal:  Noro Psikiyatr Ars       Date:  2013-12-01       Impact factor: 1.339

4.  Depression in myasthenia gravis: a heterogeneous and intriguing entity.

Authors:  Yury V Gavrilov; Tatjana M Alekseeva; Olga A Kreis; Philipp O Valko; Konrad P Weber; Yulia Valko
Journal:  J Neurol       Date:  2020-03-05       Impact factor: 4.849

5.  Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study.

Authors:  Yasushi Suzuki; Kimiaki Utsugisawa; Shigeaki Suzuki; Yuriko Nagane; Masayuki Masuda; Chiaki Kabasawa; Yuko Shimizu; Hiroya Utsumi; Shinichiro Uchiyama; Kazuo Fujihara; Norihiro Suzuki
Journal:  BMJ Open       Date:  2011-12-19       Impact factor: 2.692

6.  Fatigue in myasthenia gravis: risk factors and impact on quality of life.

Authors:  Sarah Hoffmann; Johanna Ramm; Ulrike Grittner; Siegfried Kohler; Jana Siedler; Andreas Meisel
Journal:  Brain Behav       Date:  2016-08-02       Impact factor: 2.708

7.  Prospective study of stress, depression and personality in myasthenia gravis relapses.

Authors:  Anca Bogdan; Carolina Barnett; Abdulrahman Ali; Mohammed AlQwaifly; Alon Abraham; Shabber Mannan; Eduardo Ng; Vera Bril
Journal:  BMC Neurol       Date:  2020-06-29       Impact factor: 2.474

8.  Studying the relationship between clinical features and mental health among late-onset myasthenia gravis patients.

Authors:  Lu Yu; Li Qiu; Hao Ran; Qian Ma; Ya-Ru Lu; Wei-Bin Liu
Journal:  World J Psychiatry       Date:  2022-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.